Beverley M Shields (B M Shields, Beverley Shields)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Topics

Clinical Practice

African American

Insulin Resistance

Top Venues

BMJ open diabetes research & care

Diabetic medicine : a journal of the British Diabetic Association

This page only lists publications with an associated author ORCID identifier.

Publications

Nicholas J Thomas, Anita V Hill, Colin M Dayan, Richard D Oram, Timothy James McDonald, Beverley M Shields, Angus G Jones, null null
Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes. Diabetes care (2023)
Katherine G Young, Andrew P McGovern, Inês Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J Thomas, Raphael Sonabend
HbA 1c screening for the diagnosis of diabetes. Reply to Brož J, Brabec M, Krollová P et al [letter]. Diabetologia (2023)
Nicholas J Thomas, Anita V Hill, Colin M Dayan, Richard D Oram, Timothy James McDonald, Beverley M Shields, Angus G Jones, null null
Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes. Diabetes care (2023)
Katherine G Young, Andrew P McGovern, Inês Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J Thomas, Raphael Sonabend
Correction to: The impact of population-level HbA 1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia (2023)
Anxious J Niwaha, Lauren R Rodgers, Alice L J Carr, Priscilla A Balungi, Raymond Mwebaze, Andrew T Hattersley, Beverley M Shields, Moffat J Nyirenda, Angus G Jones
Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study. BMJ open diabetes research & care 10 (2) (2022)
Katherine G Young, Andrew P McGovern, Inês Barroso, Andrew T Hattersley, Angus G Jones, Beverley M Shields, Nicholas J Thomas, Raphael Sonabend
The impact of population-level HbA 1c screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis. Diabetologia (2022)
Lewis Pang, Kevin C Colclough, Maggie H Shepherd, Joanne McLean, Ewan R Pearson, Sian Ellard, Andrew T Hattersley, Beverley M Shields
Improvements in Awareness and Testing Have Led to a Threefold Increase Over 10 Years in the Identification of Monogenic Diabetes in the U.K. Diabetes care 45 (3) (2022)
Russell J Eason, Nicholas J Thomas, Anita V Hill, Bridget A Knight, Alice L J Carr, Andrew T Hattersley, Timothy J McDonald, Beverley M Shields, Angus G Jones, null null, null null
Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation. Diabetes care (2022)
Andrew P McGovern, Michael Hogg, Beverley M Shields, Naveed A Sattar, Rury R Holman, Ewan R Pearson, Andrew T Hattersley, Angus G Jones, John M Dennis, null null
Risk factors for genital infections in people initiating SGLT2 inhibitors and their impact on discontinuation. BMJ open diabetes research & care 8 (1) (2021)
Angus G Jones, Timothy James McDonald, Beverley M Shields, William A Hagopian, Andrew T Hattersley
Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes. Diabetes care 44 (6) (2021)
Anxious J Niwaha, Lauren R Rodgers, Rosamund Greiner, Priscilla A Balungi, Raymond Mwebaze, Timothy James McDonald, Andrew T Hattersley, Beverley M Shields, Moffat J Nyirenda, Angus G Jones
HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study. BMJ open diabetes research & care 9 (1) (2021)
Jonathan M Locke, Petra Dusatkova, Kevin Colclough, Alice E Hughes, Raphael Sonabend, Beverley M Shields, Sarah E. Flanagan, Maggie H Shepherd, Emma L Dempster, Andrew T Hattersley, Michael N Weedon, Stepanka Pruhova, Kashyap Amratlal Patel
Association of birthweight and penetrance of diabetes in individuals with HNF4A-MODY: a cohort study. Diabetologia 65 (1) (2021)
Catherine Angwin, Caroline Jenkinson, Angus G Jones, Christopher Jennison, William Henley, Andrew J Farmer, Naveed Sattar, Rury R Holman, Ewan Pearson, Beverley M Shields, Andrew Hattersley, null null
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea-a MASTERMIND study protocol. BMJ open 10 (12) (2020)
Beverley M Shields, Andrew T Hattersley, Andrew J Farmer
Identifying routine clinical predictors of non-adherence to second-line therapies in type 2 diabetes: A retrospective cohort analysis in a large primary care database. Diabetes, obesity & metabolism 22 (1) (2019)
Pamela Bowman, Timothy J McDonald, Bridget A Knight, Sarah E Flanagan, Maria Leveridge, Steve R Spaull, Beverley M Shields, Suzanne Hammersley, Maggie H Shepherd, Robert C Andrews, Kashyap Amratlal Patel, Andrew T Hattersley
Patterns of postmeal insulin secretion in individuals with sulfonylurea-treated KCNJ11 neonatal diabetes show predominance of non-KATP-channel pathways. BMJ open diabetes research & care 7 (1) (2019)
S M Marren, S Hammersley, Timothy James McDonald, Beverley M Shields, B A Knight, Anita Hill, R Bolt, Timothy I M Tree, Bart O Roep, Andrew T Hattersley, Angus G Jones, Richard D Oram, null null
Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice? Diabetic medicine : a journal of the British Diabetic Association 36 (9) (2019)
Anita L Grubb, Timothy James McDonald, Femke Rutters, Louise A Donnelly, Andrew T Hattersley, Richard D Oram, Colin N A Palmer, Amber A van der Heijden, Fiona Carr, Petra J M Elders, Mike N Weedon, Roderick C Slieker, Leen M 't Hart, Ewan R Pearson, Beverley M Shields, Angus G Jones
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy. Diabetes care 42 (2) (2018)
John M Dennis, William E Henley, Michael N Weedon, Mike Lonergan, Lauren R Rodgers, Angus G Jones, William T Hamilton, Naveed Sattar, Salim Janmohamed, Rury R Holman, Ewan R Pearson, Beverley M Shields, Andrew T Hattersley, null null
Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data. Diabetes care 41 (9) (2018)
Alice E Hughes, Michael Nodzenski, Robin N Beaumont, Octavious Talbot, Beverley M Shields, Denise M Scholtens, Bridget A Knight, William L Lowe, Andrew T Hattersley, Rachel M Freathy
Fetal Genotype and Maternal Glucose Have Independent and Additive Effects on Birth Weight. Diabetes 67 (5) (2018)
John M Dennis, Beverley M Shields, Anita V Hill, Bridget A Knight, Timothy James McDonald, Lauren R Rodgers, Michael N Weedon, William E Henley, Naveed Sattar, Rury R Holman, Ewan R Pearson, Andrew T Hattersley, Angus G Jones, null null
Precision Medicine in Type 2 Diabetes: Clinical Markers of Insulin Resistance Are Associated With Altered Short- and Long-term Glycemic Response to DPP-4 Inhibitor Therapy. Diabetes care 41 (4) (2018)
Kashyap Amratlal Patel, Michael N Weedon, Beverley M Shields, Ewan R Pearson, Andrew T Hattersley, Timothy James McDonald, null null
Zinc Transporter 8 Autoantibodies (ZnT8A) and a Type 1 Diabetes Genetic Risk Score Can Exclude Individuals With Type 1 Diabetes From Inappropriate Genetic Testing for Monogenic Diabetes. Diabetes care 42 (2) (2018)
Beverley M Shields, Maggie Shepherd, Michelle Hudson, Timothy James McDonald, Kevin Colclough, Jaime Peters, Bridget Knight, Chris Hyde, Sian Ellard, Ewan R Pearson, Andrew T Hattersley, null null
Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients. Diabetes care 40 (8) (2018)
Beverley M Shields, Timothy James McDonald, Richard Oram, Anita Hill, Michelle Hudson, Pia Leete, Ewan R Pearson, Sarah J Richardson, Noel G Morgan, Andrew T Hattersley, null null
C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase. Diabetes care 41 (7) (2018)